Renaissance Technologies - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 28 filers reported holding INMUNE BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of INMUNE BIO INC
ValueSharesWeighting
Q2 2023$182
-19.1%
20,000
-42.5%
0.00%
Q1 2023$225
-99.9%
34,800
+8.4%
0.00%
Q2 2022$284,000
-31.1%
32,100
-19.8%
0.00%
Q3 2020$412,00040,0000.00%
Other shareholders
INMUNE BIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 230,500$2,351,0001.70%
Fermata Advisors, LLC 17,955$183,0000.07%
Virtu Financial LLC 24,364$249,0000.02%
YorkBridge Wealth Partners, LLC 10,369$106,0000.02%
Jump Financial, LLC 21,100$215,0000.01%
Financial Advocates Investment Management 15,167$155,0000.01%
FNY Investment Advisers, LLC 1,100$11,0000.01%
Janney Montgomery Scott LLC 113,914$1,162,0000.01%
Walleye Capital LLC 17,127$175,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 12,473$127,0000.00%
View complete list of INMUNE BIO INC shareholders